. Author manuscript; available in PMC: 2025 Jul 1.

Published in final edited form as: J Immunol Methods. 2024 May 31;530:113698. doi: 10.1016/j.jim.2024.113698

Table 1.

Characteristics of Serum Donors

Prime	Boost	F / M	Age^*	Days between doses^†
BNT162b2	None	4 / 2	44	24
mRNA-1273	None	2 / 4	52	29
Ad26.COV2.S	None	1 / 5	37	NA
NVX-CoV2373	None	1 / 4	46	28
BNT162b2	BNT152b2	3 / 2	35	218
BNT162b2	mRNA-1273	2 / 0	47	173
mRNA-1273	mRNA-1273	3 / 2	51	121
NVX-CoV2373	NVX-CoV2373	4 / 1	40	99
NVX-CoV2373	BNT162.b2	1 / 1	47	123
Ad26.COV2.S	BNT162.b2	0 / 1	43	247
Ad26.COV2.S	mRNA-1273	0 / 1	36	146

F=female, M=male,

average age at time of donation,

^†

average number of days between final dose and penultimate dose of vaccine, NA = not applicable, single vaccination.